These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 4013349)

  • 1. [Release and bioavailability of a cimetidine retard formula].
    Hillebrand F
    Wien Med Wochenschr; 1985 Apr; 135(8):191-6. PubMed ID: 4013349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of in vivo and in vitro interactions of an aluminum hydroxide, magnesium hydroxide containing antacid with cimetidine in patients with peptic ulcer.
    Allgayer H; Röllinghoff W; Paumgartner G
    Z Gastroenterol; 1983 Jul; 21(7):351-4. PubMed ID: 6613216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experiences with a cimetidine depot preparation (Neutronorm retard) in the treatment of peptic ulcer].
    Pesendorfer FX; Salocher C
    Wien Med Wochenschr; 1983; 133(4-5):123-4, 126. PubMed ID: 6344445
    [No Abstract]   [Full Text] [Related]  

  • 4. [Bioavailability of cimetidine after partial gastrectomy (author's transl)].
    Gugler R; Wolf H; Kliems G; Somogyi A
    MMW Munch Med Wochenschr; 1980 Sep; 122(39):1337-40. PubMed ID: 6780813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole-body physiologically based pharmacokinetic population modelling of oral drug administration: inter-individual variability of cimetidine absorption.
    Willmann S; Edginton AN; Kleine-Besten M; Jantratid E; Thelen K; Dressman JB
    J Pharm Pharmacol; 2009 Jul; 61(7):891-9. PubMed ID: 19589231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The absorption of cimetidine before and during maintenance treatment with cimetidine and the influence of a meal on the absorption of cimetidine--studies in patients with peptic ulcer disease.
    Bodemar G; Norlander B; Fransson L; Walan A
    Br J Clin Pharmacol; 1979 Jan; 7(1):23-31. PubMed ID: 760739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacokinetics and -dynamics of retard formation of isradipine. Summary of studies].
    Hirschberger R
    Fortschr Med; 1993 Oct; 111(30):481-4. PubMed ID: 8258429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The present state of knowledge on the treatment of peptic diseases with cimetidine].
    Romankiewicz JA; Reidenberg MM
    Internist (Berl); 1981 Dec; 22(12):762-6. PubMed ID: 6797984
    [No Abstract]   [Full Text] [Related]  

  • 9. Cimetidine 6 years later: a review.
    Gledhill T
    Can J Surg; 1983 Jul; 26(4):312-5. PubMed ID: 6134575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of duodenal ulcer with delayed-action cimetidine].
    Paes IB; da Silveira GM
    Arq Gastroenterol; 1981; 18(4):152-5. PubMed ID: 7347596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cimetidine-theophylline interaction: report of four patients.
    Bauman JH; Kimelblatt BJ; Caraccio TR; Silverman HM; Simon GI; Beck GJ
    Ann Allergy; 1982 Feb; 48(2):100-2. PubMed ID: 6121526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absorption of sustained-release theophylline tablets.
    Fagerström PO; Heintz L
    Int J Clin Pharmacol Ther Toxicol; 1983 Jul; 21(7):359-62. PubMed ID: 6885207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cimetidine and the cost of peptic ulcer in the Netherlands.
    Bulthuis R
    Eff Health Care; 1984 Apr; 1(6):297-311. PubMed ID: 10310799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and bioavailability of four modified-release ursodeoxycholic acid preparations for once-a-day administration.
    Simoni P; Sabatini L; Baraldini M; Mirasoli M; Roda A; Roda E
    Int J Clin Pharmacol Res; 2002; 22(2):37-45. PubMed ID: 12503774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation and evaluation of sustained release floating capsules of nicardipine hydrochloride.
    Moursy NM; Afifi NN; Ghorab DM; El-Saharty Y
    Pharmazie; 2003 Jan; 58(1):38-43. PubMed ID: 12622251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioavailability of theophylline from a sustained-release aminophylline formulation (Euphyllin retard tablets)--plasma levels after single and multiple oral doses.
    Schuppan D; Molz KH; Staib AH; Rietbrock N
    Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):223-7. PubMed ID: 7251238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cimetidine and peptic ulcer.
    Blaxland CJ
    Med J Aust; 1984 Nov; 141(10):681-2. PubMed ID: 6493121
    [No Abstract]   [Full Text] [Related]  

  • 18. Relative bioavailability of etofibrate. A comparison of an acute and a new sustained release formulation.
    Johnson KI; Hoppe HJ; Schatton W
    Arzneimittelforschung; 1984; 34(12):1785-7. PubMed ID: 6543315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cimetidine and peptic ulcer.
    Hetzel DJ; Hecker R; Shearman DJ
    Med J Aust; 1980 Nov; 2(11):588-9. PubMed ID: 7464614
    [No Abstract]   [Full Text] [Related]  

  • 20. Development of novel sustained-release system, disintegration-controlled matrix tablet (DCMT) with solid dispersion granules of nilvadipine (II): in vivo evaluation.
    Tanaka N; Imai K; Okimoto K; Ueda S; Tokunaga Y; Ibuki R; Higaki K; Kimura T
    J Control Release; 2006 May; 112(1):51-6. PubMed ID: 16545477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.